Hiroaki Iijima

11PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsMolecular medicineMajor global burdens of diseaseApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 29, 2024
Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

Hiroaki Iijima, Hidetoshi Shimizu, Kazumi Mori-Anai

|Feb 27, 2024
Renal outcomes with sodium-glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases.

Hiroaki Iijima, Maki Gouda, Hideaki Hida

|Dec 20, 2023
Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

Hiroaki Iijima, Hidetoshi Shimizu, Kazumi Mori-Anai

|May 14, 2021
Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database.

Koutaro Yokote, Ryo Suzuki, Maki Gouda

|Apr 15, 2021
DPP-4 Inhibitors Have Different Effects on Endothelial Low-Grade Inflammation and on the M1-M2 Macrophage Polarization Under Hyperglycemic Conditions.

Valeria De Nigris, Francesco Prattichizzo, Hiroaki Iijima

|Nov 27, 2020
Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes.

Mitsuyoshi Takahara, Toshihiko Shiraiwa, Taka-Aki Matsuoka

Pageof 2

Frequent Collaborators

3 joint publications

Maki Gouda

3 joint publications

Kazumi Mori-Anai

2 joint publications

Takashi Kadowaki

2 joint publications

Antonio Ceriello